BridgeMD
New treatment option for Coronary Syndrome, Acute, Non-ST Elevation, High Risk Patients
Official title Management Tactics for Patients High Risk With Acute Coronary Syndrome Without ST Segment Elevation and Multivessel Coronary Artery Disease
ClinicalTrials.gov ID: NCT06279663
What this study is testing
- What it's testing
- The study will include patients with acute coronary syndrome without ST segment elevation and multivessel CA lesion, who are subject to surgical treatment according to KG data (Syntax Score 23 - 32 points with significant damage to the anterior descending artery and/or trunk of the left coronary artery). The patient should be suitable for both CABG and PCI (confirmed by an X-ray surgeon and a cardiac surgeon).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Acute coronary syndrome without ST segment elevation of high risk: unstable angina pectoris or myocardial infarction requiring revascularization...
- The patient is suitable for both CABG and PCI, confirmed by an treatment cardiologist and surgeon (multivessel lesion with a Sintax score of 23-32...
- Complete myocardial revascularization (that is, the desire for the absence of hemodynamically significant coronary arteries after revascularization...
- Signed informed consent
- Age over 18 years.
You likely can't join if
- Myocardial infarction with ST segment elevation
- Stable angina pectoris
- Patients with OSN Killip II-IV class
- Patients required an immediate PCI procedure (e.g. electrical instability)
- A history of hemorrhagic stroke one year before the procedure
- Ischemic stroke or TIA in the last 6 weeks
See the full eligibility criteria
- Acute coronary syndrome without ST segment elevation of high risk: unstable angina pectoris or myocardial infarction requiring revascularization within 24 hours based on the risk of an unfavorable outcome (increase or...
- The patient is suitable for both CABG and PCI, confirmed by an treatment cardiologist and surgeon (multivessel lesion with a Sintax score of 23-32 points with significant damage to the anterior descending artery and/or...
- Complete myocardial revascularization (that is, the desire for the absence of hemodynamically significant coronary arteries after revascularization, with a diameter of \> 2.5 mm, that is, residual coronary artery...
- Signed informed consent
- Age over 18 years.
- Myocardial infarction with ST segment elevation
- Stable angina pectoris
- Patients with OSN Killip II-IV class
- Patients required an immediate PCI procedure (e.g. electrical instability)
- A history of hemorrhagic stroke one year before the procedure
- Ischemic stroke or TIA in the last 6 weeks
- The final stage of chronic renal failure requiring dialysis.
- Preliminary PCI for any other coronary artery lesion within 1 year prior to randomization.
- Pre-CABG at any time prior to randomization.
- The need for concomitant cardiac surgery, except for CABG (for example, valve surgery, aortic repair, etc.). Patients who require additional surgery (cardiological or extra-cardiac) for 1 year.
- Non-cardiac concomitant diseases with a life expectancy of less than 1 year (for example, oncological diseases). 13\. The left ventricular ejection fraction is less than 40%. 14. Severe degree of COPD
The study team makes the final eligibility decision.
Where it's taking place
- Novosibirsk, Novosibirsk Obl, Russia
- Novosibirsk, Rechkunovskaya Str., Russia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Novosibirsk, Novosibirsk Obl, Russia; Novosibirsk, Rechkunovskaya Str., Russia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.